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Insulitis  has  been  observed  in  the  pancreas  of children  with  insulin-dependent 
diabetes  mellitus  (IDDM) 1 of <6-mo duration  (1).  The cause of the insulitis  is not 
known,  but  it  has  been  suggested  that  viral  infections  and/or  immunopathologic 
mechanisms may play a role in the etiology and pathogenesis of IDDM (2). Recently, 
autoantibodies that bind to cytoplasmic and surface antigens on pancreatic islet  cells 
have been found in the sera of many patients with IDDM, but not in the sera of non- 
insulin-dependent diabetics (3-6). Some patients with IDDM also suffer from a more 
generalized polyendocrine disorder and have autoantibodies in their sera that react 
with other hormone-producing cells (e.g., thyroid, gastric mucosa, adrenal, pituitary) 
(3, 4, 7, 8). 
What it is that triggers the production of autoantibodies in IDDM is not known, 
but  viruses have often been suspected as a  cause of autoimmune disease  (9).  Auto- 
antibodies to host antigens (e.g., DNA, lymphocytes, erythrocytes, immunoglobulins, 
smooth muscle, myelin) have been observed after certain viral infections (10-14), and 
Epstein-Barr virus is known to be a  polyclonal activator (15).  Transient antibody to 
cytoplasmic islet  cell antigens also has been observed in some patients after mumps 
infection (16). 
This  investigation  was  initiated  to see  whether  viruses  that  produce diabetes  in 
animals also would trigger an autoimmune response.  Earlier studies from our labo- 
ratory showed  that  reovirus  type  3  could  infect  pancreatic beta  cells  in  mice and 
produce diabetes  (17).  We now report that reovirus type 1 also produces diabetes in 
mice, but in addition triggers a  polyendocrine disease and induces autoantibodies to 
insulin and growth hormone (GH). 
Materials and Methods 
Animals.  NIH-Swiss and SJL/J mice were obtained from the National Institutes  of Health 
(NIH) Small Animal Section, Bethesda, Md. and The Jackson Laboratory, Bar Harbor, Maine, 
respectively.  Newborn  mice  (3-6 d  old)  of both sexes were  inoculated  intraperitoneally  or 
intracerebrally  with 5 ×  10  5 or 5 ×  10  4 plaque-forming units (pfu) of virus, respectively. Except 
where indicated,  NIH-Swiss mice, inoculated  intraperitoneally,  were used. 
Viruses and Cell Cultures.  Reovirus type 1 (Lang strain) and reovirus type 3 (Dearing strain) 
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were  passaged  in SJL  mouse pancreatic beta cell  cultures (18) unless indicated otherwise. 
Recombinant viruses 1.HA3, 3.HA 1, and clone 94 were kindly provided by Dr. Bernard Fields, 
Harvard Medical School, Boston, Mass. and passaged in L-929 cells (19, 20). All titrations were 
performed on L-929 monolayers using an agar overlay. The D clone of encephalomyocarditis 
(EMC) virus (21) was grown and titrated in secondary mouse embryo cells. 
Anti-Viral Sera.  Type-specific goose sera against reovirus type  1 and reovirus type 3 were 
obtained from the  Research  Resource Branch, National Institute of Allergy and Infectious 
Diseases, NIH and used to identify the different reoviruses by means of a standard hemagglu- 
tination inhibition test  with  human  type  O  erythrocytes  for  reovirus  type  1 and bovine 
erythrocytes for reovirus type 3 (20). Rabbit antibody to reovirus type 1 or mouse antibody to 
reovirus type 3 (Microbiological Associates,  Walkersville, Md.) was used in direct immunoflu- 
orescence tests after labeling with fluorescein-isothiocyanate  (FITC) by standard methods (17). 
Detection of Viral Antigens by Direct Immunofluorescence.  Cryostat sections (5/zm thick) of tissue 
from infected and uninfected animals were fixed in acetone for 5 rain at room temperature, 
flooded with FITC-labeled anti-viral serum, incubated at  7°C overnight, and examined by 
fluorescent microscopy (17). 
Detection of Autoan~ibodies by Indirect Immunofluorescent.  Unfixed frozen sections of pancreas, 
pituitary, stomach, thyroid, adrenals, ovaries, and testes were obtained from uninfected adult 
mice  and  incubated for  45  min at  37°C  with  various dilutions of sera  from  infected or 
uninfected mice. After gentle washing, the sections were further incubated overnight at  7°C 
with an appropriate dilution of FITC-labeled rabbit anti-mouse IgO (heavy and light chain; 
Miles Laboratories Inc., Elkhart,  Ind.). Background staining was  assessed  by using normal 
mouse sera. 
In other experiments, organs from uninfected mice were fixed  in Bouin's solution for 6 h 
(room temperature), washed five times in 70% ethanol, embedded in paraffin, and sectioned. 
The sections were then incubated with serum from infected or uninfected mice and stained 
with FITC-labeled anti-mouse IgG as described above. Autoantibodies could be detected by 
both methods but, in general, Bouin's-fixed tissue yielded better results than unfixed frozen 
sections. 
Antibodies to Hormones as Measured by Enzyme-linked Immunosorbent Assay (ELISA).  The antigens 
used in these tests were highly purified preparations of rat GH (GH-RP- 1 or iodination-grade 
GH-I-4 obtained  through  the  courtesy  of Dr.  A.  F.  Parlow,  National  Pituitary Agency, 
Baltimore, Md.) and rat insulin (Novo Industries, Copenhagen, Denmark). Mieroelisa plates 
(Cooke  Engineering Co.,  Alexandria, Va.)  containing 96  wells  were  coated  with  diluted 
hormones (i.e., 9.2 #g/well of GH or 0.8 #g/well of insulin) in 0.1 ml of carbonate-bicarbonate 
buffer, pH 9.6,  overnight at  4°C.  After three washes,  serial twofold dilutions of sera  from 
infected or uninfected mice in phosphate-buffered saline-Tween 20 were added to the wells and 
incubated for 2 d at 4°C. Pilot experiments showed that this long incubation was required for 
optimal sensitivity. The wells then were washed three times and the amount of antibody bound 
to the antigen was measured by adding an excess of horseradish peroxidase (HRPO)-conjugated 
anti-mouse immunoglobulin (45 min at room temperature) and orthophenylenediamine (Ald- 
rich Chemical Co.,  Milwaukee, Wise.)  as substrate (22). The class of anti-hormone antibody 
was assessed using HRPO-conjugated anti-mouse IgG (Miles Laboratories Inc.) or anti-mouse 
IgM (Litton Bionetics, Kensington, Md.) conjugated in our laboratory with HRPO (electron 
microscope grade; Tousimis Co., Rockville, Md.) by the periodate method (23). Specificity of 
the assay was checked with mouse sera (from infected and uninfected animals) using a battery 
of protein antigens (e.g.,  prolactin, glucagon, albumin, ribonuclease B)  and comparing the 
results with specific antisera to GH and insulin. Absorbance was read with a microplate reader 
(Flow Laboratories, Inc., Rockville, Md.) and antibody titer to hormones was expressed  as the 
reciprocal of the highest dilution of serum yielding a sample:control ratio of 2.0 or greater. By 
this method, hyperimmune sera to GH and insulin gave titers of 800 and 32,000, respectively 
(A. Toniolo, manuscript in preparation). 
Measurement of Hormones by Radioimmunoassay (RIA).  Insulin and glucagon were extracted 
from mouse pancreas (18, 24) with slight modifications including  the use of a protease inhibitor 
(aprotinin; Sigma Chemical Co.,  St.  Louis, Mo.).  Immunoreactive insulin was measured by 
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by Dr. Lillian Recant, Veterans Administration Hospital, Washington, D. C. GH was measured 
by a double-antibody RIA (25) using lSSI-labeled rat GH. Individual mouse sera were tested 
after ultricentrifugation  (130,000 g for 90 rain) to eliminate  immune complexes. 
Prolactin Receptor Assay.  Prolactin  receptors were evaluated by measuring the amount of 125I- 
labeled  ovine  prolactin  (National  Pituitary Agency)  that  specifically bound to mouse  liver 
membrane preparations  (26) from  infected  and uninfected  mice. In brief,  labeled  prolactin 
(80,000 cpm) was incubated with liver membrane (0.14-0.31 mg protein)  in final vol of 0.5 ml. 
After overnight  incubation at room temperature,  the reaction was stopped by adding 1.0 ml of 
Tris buffer at 4°C. The tubes were centrifuged  at 2,500 g for 20 min, the pellets washed two 
times, and the radioactivity measured.  The amount of radiolabeled  prolactin (cpm) bound in 
the presence of 0.5/~g unlabeled  hormone was used as the value  for nonspecific binding and 
was subtracted from total binding (26). 
Glucose Assay.  Glucose  in  the blood was measured  by the  glucose oxidase  assay with o- 
dianisidine  dihydroehloride  as the indicator dye. Blood for glucose tolerance tests was obtained 
60 min after i.p. injection of 2 mg of glueose/g body weight (17). 
Pathology.  For  light  microscopy,  tissues  were  fixed in  buffered  formalin,  embedded  in 
paraffin,  and stained  with hematoxylin  and eosin. For electron  microscopy, tissues were fixed 
in  2.5% glutaraldehyde and  1%  osmium  tetroxide,  embedded in  Epon 812  (Tousimis  Co.), 
stained  with  uranyl  acetate  and  lead  citrate,  and  examined  with  a  Philips  201  electron 
microscope (Philips Electronic  Instruments,  Inc., Mahwah, N. J.). 
Results 
Hyperglycemia and Infection of the Islets of Langerhans.  Mice were infected with reovirus 
type 1 and at different times thereafter, glucose, insulin, and glucagon were measured. 
The data in Fig.  1 A and B show that although only a small percentage of mice had 
elevated nonfasting glucose levels,  abnormal glucose tolerance tests were observed in 
up to 45% of the animals with some values >400 mg/dl. Pancreatic immunoreactive 
insulin was depressed  beginning at  3 d  after infection and remained lower than  in 
controls  throughout  the  experiment  (Fig.  1 C).  In  contrast,  plasma  glucagon was 
unchanged or slightly elevated (Fig.  1 D). 
Evidence that the metabolic alterations were secondary to changes in the pancreatic 
islets  of Langerhans came from histologic, immunofluorescence, and electron micro- 
seopic  studies.  By  light  microscopy,  focal  degenerative  cytoplasmic  changes  and 
pynotic nuclei were found in about one-fourth of the islets  between 5 and  7 d  after 
infection  (Fig.  2A).  7-9  d  after  infection,  focal  necrosis  and  disruption  of  islet 
architecture were observed in approximately one-fifth of the islets.  Mononuclear and 
occasional  polymorphonuclear cells  also  were  observed  infiltrating  islets  and  the 
interstitial  connective tissue;  later  (i.e.,  3  wk),  large  numbers  of plasma  cells  sur- 
rounded and infiltrated the peripheral area of many islets  (Fig.  2 B).  In the exocrine 
portion of the pancreas, minimal focal necrosis of acinar tissue and minimal periductal 
cell infiltrates with some degree of ductal obstruction were observed in many of the 
mice. 
By  immunofluorescenee,  viral  antigens  were  found  in  the  islets  of Langerhans 
beginning at  5  d  after  infection,  but  generally were  not  detected  after  12  d.  The 
intensity of fluorescence was greatest at 7 d and at that time, approximately one-half 
of the islets  contained some viral antigens. In general, <20% of the cells  within any 
one islet  were positive by immunofluorescence but, in some cases, almost the entire 
islet showed bright fluorescence (Fig.  2 C). By electron microscopy, viral particles were 
seen primarily in beta cells,  but also in some alpha and delta cells  (Fig. 2 D  and E). 
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FIG.  1.  Alterations of glucose, insulin, and glucagon after infection with reovirus type 1. Shaded 
areas represent the mean of uninfected mice + 2 SD. In panels A and B, each point represents the 
glucose concentration of an individual mouse. In panels C and D each point represents the mean 
:t: SD of  seven to ten infected mice. (A) Nonfasting glucose, (B) glucose tolerance test, (C) pancreatic 
immunoreactive insulin (IRI), and (D) plasma glucagon. 
work, we observed that a  number of mice were runted. To study this in more detail, 
mice were infected and at different times thereafter weights were determined  (Fig. 3) 
and clinical evaluations made.  At  14,  21, and 35 d  after infection 49, 48 and  25% of 
reovirus-infected mice, respectively,  showed significant  retardation  in  growth  (i.e.,  2 
SD below  the  mean  of the uninfected  mice)  as compared with  uninfected  controls. 
Moreover,  at  2-3  wk  after  infection,  -75%  of the  mice  with  retarded  growth  also 
displayed oily hair and/or steatorrhea;  45% showed thinning of hair and/or alopecia; 
and >--20% had ascites. 
The retardation  in growth raised the possibility that the virus might be damaging 
cells in the pituitary. At 7-14 d after infection, light microscopy revealed inflammatory 
infiltrates of mononuclear cells and focal areas of coagulation necrosis in the anterior 
lobe of the pituitary,  but  not in the intermediate  or posterior lobes. Immunofluores- 
cence showed that viral antigens also were present in the anterior, but not the posterior 
lobe  of the  pituitary  (Fig.  4A),  and  electron  microscopy revealed  viral  particles  in 
growth hormone-producing cells (Fig. 4 B), especially in the areas where focal necrosis 
was observed. 
To see whether  the  virus-induced  pathology in  the pituitary  might  be associated 
with  alterations  in  hormones,  GH  levels  in  the  blood  were  measured.  Although 
considerable  variation  was  observed  among  animals,  a  significant  decrease  in  the 
mean GH concentration was found at  14 d  after infection in runted  as compared to ONODERA,  TONIOLO,  RAY, JENSON,  KNAZEK,  AND  NOTKINS  1461 
Fro.  2.  Microscopic changes in pancreatic islets of Langerhans of mice infected with reovirus type 
1.  (A)  Focal  degenerative  cytoplasmic  changes  and  pynotic  nuclei  with  loss  of  normal  islet 
architecture seen 7 d  after infection. Arrows mark periphery of islet; hematoxylin and eosin (HE). 
×  550.  (B) Mononuclear cells, especially plasma cells (arrows), are seen infiltrating and surrounding 
an islet at 21 d after infection. HE. ×  550.  (C) Frozen section from pancreas taken 7 d after infection 
and  stained with  FITC-labeled  antibody to  reovirus  type  1.  Viral  antigens seen  in  many  cells 
throughout the islet. The surrounding acinar cells are relatively free of viral antigens. ×  340.  (D) 
Electron micrograph of cells in mouse pancreas 7 d after infection with rcovirus type 1. Pancreatic 
beta  cell  with  insulin-containing  granules  (small  arrows)  is  located  between  two  alpha  cells 
containing  characteristic  glucagon-containing  granules  (large  arrows).  The  three  cells  contain 
cytoplasmic reovirus  particles  (RV)  in  different stages of development.  In  the  alpha cell  (top), 
reovirus  particles  are  in  crystalline array.  In  the  beta  cell  (middle),  the  virus  particles  form  a 
reticulo-granular matrix along lines of aggregated matrix material. In the alpha cell (bottom), virus 
particles are seen in a  phagocytic vacuole.  ×  14,000.  (E)  Pancreatic delta cell with characteristic 
somatostatin-containing  granules  (arrows)  and  reticulo-granular  matrix  containing  developing 
reovirus particles (RV). ×  20,000. 1462  VIRUS-INDUCED  DIABETES  MELLITUS 
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Flo.  3.  Growth  retardation of mice infected with reovirus type 1. Mice were weighed at the times 
indicated and the weight distribution plotted as a percentage. Open bars, uninfected mice; shaded 
bars, infected mice. Arrows represent the mean weight of each group. Data from several experiments 
were pooled. The number of mice in the uninfected groups on days 7, 14, 21, and 35 were 26, 53, 64, 
and 31, respectively. The number of mice in the infected groups on the same days were 58, 92, 70, 
and 51, respectively. 
non-runted mice or uninfected controls (P <0.001)  (Fig. 5 A). Because GH concentra- 
tion is one of the factors that regulates prolactin receptors  (26), we also measured the 
binding of 125I-prolactin to receptors on liver membranes. The data in Fig.  5 B  show 
that at  14 d  after infection, the binding of prolactin was reduced by almost 60% in 
runted as compared with nonrunted mice or uninfected controls (P <0.005). 
Autoantibodies.  Because  runting  can  be  immunologically  induced  (27,  28)  and 
autoimmunity may contribute to the pathogenesis of IDDM  (6), we decided to look 
for  autoantibodies in the sera of infected mice.  Sera  were tested  by indirect immu- ONODERA,  TONIOLO, RAY, JENSON,  KNAZEK, AND NOTKINS  1463 
Ftc. 4.  Viral antigens and viral particles in the anterior pituitary of mice 7 d after intracerebral 
infection with reovirus type 1. (A) Frozen  section stained with FITC-labeled antibody to reovirus 
type 1. Viral antigens are found in the anterior (AP), but not in the intermediate or posterior (PP) 
lobes of the pituitary.  ×  240. (B)  Electron micrograph of anterior pituitary showing a cell with 
growth hormone-containing granules (arrows) and reovirus particles (VP) that are either single or 
in crystalline array. ×  14,000. 
nofluorescence for the presence of autoantibodies to pancreas, pituitary, stomach wall, 
intestine, adrenals, thyroid, ovaries, and testes  obtained from  uninfected mice.  By 
immunofluorescence, autoantibodies were found that reacted with cells in the islets of 
Langerhans, anterior pituitary, and  stomach  wall.  As  seen  in  Fig.  6A,  sera  from 
reovirus-infected  mice  stained  islet  cells,  but  not  the  surrounding acinar  tissue. 
Particularly brilliant fluorescence was  sometimes observed at  the  periphery of the 
islets  where  alpha  and  delta  cells  are  located.  Staining also  was  observed  in  the 
anterior, but not  in the  intermediate or  posterior lobes of the  pituitary (Fig.  6 B). 1464  VIRUS-INDUCED DIABETES  MELLITUS 
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F~c. 5.  Effect of reovirus type 1 on growth hormone concentration  and prolactin receptors. Mice 
were infected intraperitoneally with reovirus, and  14 d later all the animals were weighed. Mice 
were scored as runted if their body weights were ----.2  SD below the mean of uninfected  controls. 
Each point represents an individual animal. The mean +  SE is shown by vertical lines and bars. 
(A) Concentration  of growth hormone in plasma; (B) binding of l=nI-prolactin  to receptors on liver 
membranes. 
Staining of the stomach wall was usually weaker and primarily localized to the crypts, 
possibly parietal cells (data not shown). No staining was observed with the intestines, 
adrenals, thyroid, ovaries, or testes. 
To determine the nature of the antigens involved, sera that contained autoantibod- 
ies were absorbed with growth hormone or insulin. As seen in Table I, autoantibodies 
to  the  anterior  pituitary were  absorbed  by  rat  GH,  which  antigenically is  closely 
related to mouse GH, but not by bovine GH, which antigenically is poorly related to 
mouse  GH  (29).  Absorption  with  insulin  also  failed  to  reduce  the  titer  of  this 
autoantibody.  In  contrast,  sera  containing  autoantibodies  to  islet  cells  could  be 
absorbed by insulin, but not by rat GH. 
To be sure that the antibodies to GH and insulin were being induced by the viral 
infection  and  not  by  contaminating  hormones  in  the  viral  inoculum,  mice  were 
infected with homogenates of uninfected beta cells or L  cells that had been used to 
propagate  the  virus.  None  of these  preparations  induced  autoantibodies to  GH  or 
insulin. Moreover, as seen in Table I, mice infected with the diabetogenic D  variant 
of EMC virus (21) failed to induce autoantibodies. Attempts to induce autoantibodies 
in newborn mice with two other viruses (i.e., mumps and Coxsackie B4), thus far have 
been unsuccessful. 
The time of appearance and duration of autoantibodies are shown in Table II. By 
immunofluorescence, antibodies to pituitary cells were found in  100% of the mice at 
7 d  after infection and 63% of the mice were still positive at 40 d. Antibodies to islet 
cells were found in only 44% of the mice when measured at  14 d, and 33% remained 
positive  at  40  d.  In  general,  sera  from  infected  mice  that  were  rusted  produced 
stronger fluorescence than sera from infected non-rusted mice (data not shown). 
Additional information on the nature of the antigens and the titer of the autoanti- 
bodies comes from studies in which purified GH or insulin was bound to plastic wells ONODERA, TONIOLO,  RAY, JENSON,  KNAZEK, AND  NOTKINS  1465 
FIG. 6.  Autoantibodies in sera of reovirus-infected mice detected by indirect immunofluorescenee. 
(A) Section of normal mouse pancreas  (Bouin's  fixed)  incubated with sera obtained from runted 
mice  14  d  after  infection.  Photomicrograph  shows  cytoplasmic staining of cells  in  the  islets  of 
Langerhans  with little if any staining of surrounding  acinar cells.  X  340. (B)  Section of normal 
mouse pituitary (Bouin's  fixed) incubated with sera obtained from runted mice 14 d after infection. 
Brilliant fluorescence  is seen in the anterior lobe of the pituitary (AP). The intermediate (IP) and 
posterior (PP)  lobes show little if any fluorescence.  X  680. 
and  the  antibodies  measured  by  ELISA.  As  seen  in  Fig.  7A,  within  10  d  after 
infection, all of the mice had antibodies to GH  with a  titer -->20 and in a  few mice the 
titer was >--160.  After  10  d  the antibody  titer began  to decline and  at  30  d,  -60%  of 
the mice had  titers <10.  Fig.  7 B  shows that  the antibody  titer to insulin ranged  from 1466  VIRUS-INDUCED DIABETES  MELLITUS 
TABLE  I 
Autoantibodies  in the Sera of Reovims-infected Mice to Pancreatic Islets and 
Anterior Pituitary 
Sera 
Titer* 
Anterior  Pancreatic 
pituitary  islets 
Uninfected mice  <2  <2 
Reovirus type 1-infected:~ 
Unabsorbed  256  16 
Absorbed with bovine insulin§  256  4 
Absorbed wiht bovine GH  256  ND¶ 
Absorbed with rat GH  4  16 
EMC virus-infectedl]  <2  <2 
* Titer represents the reciprocal of the highest dilution of serum giving positive 
cytoplasmic fluorescence on Bouin's-flxed  tissue from uninfected mice. 
Pooled sera obtained 21 d after infection with reovirus type 1. 
§ Absorptions were carried out  by incubating sera with insulin or GH  (0.5 
mg/ml) for 12 h at 4°C. 
II Pooled sera obtained 21 d after infection with EMC virus. 
¶ Not done. 
TAaLE  II 
Appearance  and Duration  of Autoantibodies  as Determined  by 
lmmunofluoresence 
Sera* 
Days after in-  Pituitary:[:  Islets:[: 
fection 
Unin-  Infected  Uninfected  Infected  feeted 
% positiv~ 
7  0  100  ND  u  ND 
14  0  78  0  44 
21  0  75  0  28 
28  0  81  0  33 
40  0  63  0  33 
*  3-d-old  mice were infected with reovirus  type 1. Uninfected mice served as 
controls.  Individual sera from 5 to 14 mice were tested at each of the times 
indicated by indirect immunofluorescence. 
Sera were incubated with Bouin's-fixed sections of pituitary and pancreas 
from uninfected mice. 
§Sera  at  a  1:2  dilution  giving  cytoplasmic fluorescence  were  considered 
positive. 
[[ Not done. 
10 tO  160, but at each of the times evaluated, fewer mice had antibody to insulin than 
to GH. 
It  is  well  documented  that  reovirus produces clinical  disease when  inoculated in 
newborn  or  very  young  mice,  whereas  older  mice  are  far  more  resistant  to  the 
development of clinical disease (30). To see whether the capacity of reovirus to induce 
autoantibody  to GH  was age dependent,  mice were infected at  different times after ONODERA,  TONIOLO, RAY, JENSON,  KNAZEK, AND NOTKINS  1467 
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FIG.  7.  Titer of autoantibodies to GH (A) and insulin (B) in the plasma of reovirus-infected  and 
control mice as determined by ELISA. Each point represents an individual animal. (O) Uninfected 
mice; (O) infected mice. 
TABLE  III 
Age-dependent Induction of Autoantibody to GH by Reovirus Type 1 
Age at infection 
Days after infection 
14  21  30 
d  %  positive* 
3  100  100  100 
14  100  67  67 
30  0  0  0 
* Sera from individual mice were tested at the times indicated for antibody to 
growth hormone by ELISA. Sera with a titer ~10 were considered positive. 
Each group contained 7-10 mice. 
birth.  The  data  in Table III show  that  antibody to  GH, as  measured by ELISA, 
developed in 100% of the mice inoculated at 3 and  14 d  of age, whereas none of the 
mice inoculated at  30  d  of age  showed  a  rise  in antibody to  GH.  Similarly, mice 
inoculated at 30 d  of age failed to develop autoantibodies to insulin as measured by 
ELISA, nor to antigens in islet or pituitary cells as evaluated by immunofluorescence 
(data not shown). 
In the ELISA studies described thus far, a  peroxidase-labeled anti-mouse IgG was 
used.  Evidence that  reovirus  also  induces IgM  autoantibodies comes  from  studies 
using a  peroxidase-labeled antimouse IgM. In these experiments, 27 and 83% of the 1468  VIRUS-INDUCED DIABETES  MELLITUS 
mice, respectively, had IgM antibodies to insulin and GH at  10 d after infection. The 
IgM response was transient and only a  few of the mice still had IgM autoantibodies 
at  14 and  21  d.  In contrast,  total serum IgG and  IgM in reovirus-infected mice on 
days  14  and  21,  as  measured  by radial  immunodiffusion,  were approximately two 
times higher than in uninfected controls. 
Molecular Basis of Reovirus-induced Autoantibodies. Reovirus has a  segmented genome 
with  10 different genes and the S1  gene codes for an outer capsid polypeptide (sigma 
1)  which  is the hemagglutinin and the determinant  of viral tropism (19,  20).  In the 
experiments described thus far, reovirus type  1 was used.  Preliminary studies in our 
laboratory showed that reovirus type 3 failed to induce autoantibodies to GH. To see 
if a  specific segment of the viral genome was required  for the induction  of autoanti- 
bodies, recombinants between reovirus type 1 and type 3 were used. As seen in Fig. 8, 
reovirus type  1, but not reovirus type 3, induced  autoantibodies to GH. When mice 
were infected with recombinant 3.HA1  (i.e.,  nine genes from reovirus type 3 and the 
S1  gene  from  reovirus  type  1),  all  the  mice  developed  autoantibodies  to  GH.  In 
contrast,  when  mice were  infected  with  recombinant  1.HA3  (i.e.,  nine  genes  from 
reovirus type  1 and the S1  gene from reovirus type 3), none of the mice developed 
autoantibodies  to  GH.  Similarly,  mice infected  with  clone  94  (i.e.,  a  recombinant 
containing five genes from reovirus type 1 and five genes, including S 1, from reovirus 
type 3)  did not develop autoantibodies to GH. These experiments show that the S1 
gene  from reovirus  type  1,  which  codes  for the  hemagglutinin,  is  required  for the 
induction of autoantibodies to GH. 
The final experiment was designed to study the relation between the S 1 gene and 
the capacity of the virus to infect the pituitary. The data in Table IV, obtained by 
direct  immunofluorescence,  show  that  reovirus  type  1  and  recombinant  3.HA1 
infected the anterior, but not the posterior or the intermediate pituitary. In contrast, 
reovirus type 3,  recombinant  1.HA3  and  recombinant  clone 94 failed to infect  the 
anterior pituitary. Minimal involvement was sometimes observed in the intermediate 
and posterior pituitary. As a  control, the capacity of these viruses to infect neuronal 
and ependymal tissues (19, 20) was evaluated in the same group of animals. Reoviruses 
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FtG.  8.  Titer of autoantibody (Ab) to growth hormone, as determined by ELISA, in sera of mice 
infected with reovirus type  1, type 3, and recombinant viruses. Mice were inoculated intraperito- 
neally with the different viruses which had been passaged in L-929 cells and the animals were tested 
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TABLE IV 
Tissue Tropism of Recombinant Reoviruses as Evaluated by Immunofluorescence 
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Infecting virus* 
Localization of viral antigens:]: 
Pituitary  Brain 
Interme-  Poste- 
Anterior  diate  rior  Neurons  Ependyma 
Type  1  ~-++  -  -  -  +++ 
Recombinant  3.HAl  +++  -  -  +  +++ 
Type 3  -  +  -  +++  - 
Recombinant  1.HA3  -  +  +  +++  - 
Recombinant  clone 94  -  -  -  +++  - 
* Viruses  were  propagated  in  L-929  cells  and  mice  were  inoculated  intracerebrally.  Frozen  sections  of 
pituitary and brain obtained 7 d  after infection were stained with FITC-labeled antisera to reovirus types 
1 or3. 
Approximately  10 pituitaries and 5  brains were examined from each of the virus-infected groups and at 
least 20 sections were prepared from each organ:  (-)  no fluorescence;  (+)  fluorescence in an occasional 
cell;  (++)  fluorescence in 5-20% of cells;  (+++)  fluorescence in >20% of cells. 
having the S1  gene from type 1 infected ependymal cells, whereas reoviruses having 
the S 1 gene from type 3 infected neuronal cells. 
Discussion 
By immunofluorescence, we found that mice infected with reovirus type 1 developed 
autoantibodies  to cytoplasmic antigens  in  pancreatic  islets,  anterior pituitary,  and 
gastric mucosa. Because these tissues contain hormone-producing ceils and certain of 
these hormones are available in pure form, we were able to show by both absorption 
studies and by ELISA that sera from reovirus-infected animals contained autoanti- 
bodies to GH and insulin. A variety of controls demonstrated that reovirus infection, 
and not contamination of the viral inoculum with hormones or other tissue antigens, 
was responsible for the development of autoantibodies. Further evidence came from 
experiments with reovirus types 1 and 3 which demonstrated that only virus contain- 
ing the  type  1 hemagglutinin  induced  autoantibodies  to GH.  The possibility that 
reovirus induces autoantibodies to other hormones and host cell antigens, including 
surface antigens, is presently under investigation. 
In  addition  to  autoantibodies,  many  of the  mice  infected with  reovirus  type  1 
developed polyendocrine disease. The diabetic picture was similar to that previously 
reported with reovirus type 3, except that alpha, beta, and delta cells were infected, 
rather than just beta cells (17). A possible explanation for the transient nature of the 
glucose abnormalities  (Fig.  1) may be that beta cells from newborn mice regenerate 
faster than beta cells from older mice (31). Many of the mice also developed a runting 
syndrome  characterized  by  retarded  growth,  oily  hair,  alopecia,  and  steatorrhea. 
Runting has been observed with reovirus type 3, but in <3% of the infected mice (32). 
In our experiments with reovirus type  1, 25-50% of the mice showed some signs of 
runting.  The precise cause of virus-induced runting is not known  (32, 33), but it is 
thought to be immunologically mediated because graft-vs.-host reactions also lead to 
runting (27, 28). The present study, however, suggests another possibility; that a GH 
deficiency, especially  during  the  neonatal  period,  may  at  least  contribute  to  the 
retarded growth component of the runting syndrome. This could result directly from 1470  VIRUS-INDUCED DIABETES MELLITUS 
the  replication  of the  virus  and  the  destruction  of infected  cells  in  the  anterior 
pituitary.  Alternatively,  virus-induced  autoantibodies  to  hormones  or  to  surface 
antigens on hormone-producing cells might result in a hormone deficiency by binding 
to  hormones  in  the  blood  or  by  destroying  hormone-producing cells  (8,  34,  35). 
Deposition of immune complexes (e.g., hormone-antibody) also might lead to some of 
the  manifestations  of the  runting syndrome (36).  The relative contribution  to the 
clinical  picture of virus-induced cell destruction  versus  virus-induced autoimmune 
immunopathology  remains  to  be  clarified.  Experiments  in  progress  (T.  Onodera, 
unpublished data) indicate that the severity of the hyperglycemia and runting can at 
least  be  partially  reduced  if animals  are  treated  with  immunosuppressive  agents 
before infection. 
Precisely how a  virus infection causes the host to make antibodies against its own 
tissue  is  not  known,  but  a  variety  of mechanisms  have  been  proposed  (9).  One 
possibility is that the virus induces autoantibodies to certain antigens by interacting 
with cells containing those antigens.  For example, the virus might insert, expose or 
modify antigens in the plasma membrane of the host cell (i.e., act as a hapten), or the 
infection might  lead  to  the  release of host  antigens  in  precursor  forms  (e.g.,  pre- 
proinsulin, proinsulin, pre-GH) not ordinarily presented to the immune system (37- 
39).  Alternatively,  the  virus  might  induce  autoantibodies  by  lysing  or  activating 
subpopulations  of lymphocytes  (e.g.,  helper  or  suppressor  cells)  that  regulate  the 
immune  response  of the  host  (40,  41).  Evidence  that  reovirus  type  1 directly or 
indirectly affects the immune system comes from histopathology studies which indicate 
that at least in severly runted mice, there is some damage to the thymus and depletion 
of lymphocytes in the thymic-dependent areas of the spleen (T. Onodera, unpublished 
data). 
With  recombinant  viruses,  we  have  identified  the  segment  of the  viral  genome 
required for the induction of autoantibodies to GH. These studies showed that  the 
essential gene segment is S1, which codes for the hemagglutinin. The hemagglutinin 
binds to receptors on the surface of cells and thus determines the tropism of the virus. 
Weiner et al.  (19,  20)  showed that  reoviruses containing the type  1 hemagglutinin 
infect ependymal cells, whereas reoviruses containing the type 3 hemagglutinin infect 
neurons. Our immunofluorescence studies confirm these observations and, in addition, 
show that viruses with the type 1 hemagglutinin, but not the type 3 hemagglutinin, 
infect cells in the anterior pituitary. Moreover, because only viruses with the type 1 
hemagglutinin induce autoantibody to GH, this suggests that the interaction of virus 
with  cells containing GH  is  required  for the induction of autoantibody.  Although 
Weiner et al. (42), recently reported that type 3, but not type 1, virus binds to murine 
lymphocytes, we cannot exclude the possibility that specific subpopulations of lym- 
phocytes may have receptors for reovirus type 1 and that the interaction of virus with 
these lymphocytes may trigger autoantibodies. Thus, it is possible that  infection of 
hormone-producing cells plus  interaction of virus with cells of the immune system 
(e.g., polyclonal activation) may be required to initiate autoantibody production. 
It is well known that after the initial onset of IDDM, many patients experience a 
remission, lasting from several weeks to months, and require little if any insulin. This 
remission or "honeymoon period" is followed by an exacerbation characterized by a 
permanent  increase  in  the  requirement  for  exogenous  insulin  (43).  It  has  been 
suggested that the initial damage to beta cells may be caused by an environmental ONODERA, TONIOLO,  RAY, JENSON,  KNAZEK, AND NOTKINS  1471 
insult  (e.g.,  viruses,  chemicals,  drugs)  (44)  and  that  this  is  followed  by  a  slower 
destructive  process,  perhaps  due  to  autoimmune  immunopathology  (2,  6).  The 
demonstration  that  reovirus can both damage hormone-producing cells and induce 
an autoimmune response lends credence to the hypothesis that diabetes mellitus and 
other diseases with an autoimmune component may sometimes be triggered by viral 
infections. 
Summary 
Mice  infected  with  reovirus  type  1  developed  transient  diabetes  and  a  runting 
syndrome.  The  diabetes  was  characterized  by  hyperglycemia,  abnormal  glucose 
tolerance  tests,  and  hypoinsulinemia.  Inflammatory cells  and  viral  antigens  were 
found in the islets of Langerhans, and virus particles were seen in alpha, beta, and 
delta cells.  The runting  syndrome consisted of retarded  growth, oily hair, alopecia, 
and  steatorrhea.  Inflammatory cells and viral antigens were found  in  the anterior, 
but  not  posterior pituitary.  Electron  microscopy revealed virus particles  in  growth 
hormone (GH)-producing cells and radioimmunoassay showed that the concentration 
of GH in the blood was decreased. 
Examination  of sera from infected  mice revealed autoantibodies  that,  by immu- 
nofluorescence, reacted with cytoplasmic antigens in the islets of Langerhans, anterior 
pituitary,  and  gastric mucosa of uninfected  mice. Absorption studies  and  enzyme- 
linked immunosorbent assays designed to identify the reactive antigens showed that 
some of the autoantibodies were directed against insulin and others against GH. 
Reovirus type 3, in contrast  to reovirus type  1, did not  induce  autoantibodies to 
GH. By use of recombinant viruses, the segment of the reovirus genome responsible 
for the  induction  of autoantibodies  to GH was identified.  Virus containing  the  S1 
gene segment  from reovirus  type  1,  which  codes for the  sigma  1 polypeptide  (i.e., 
hemagglutinin), infected cells in the anterior pituitary and induced autoantibodies to 
GH, whereas  virus  containing  the  S1  gene segment  from reovirus  type  3  failed  to 
infect cells in  the anterior pituitary and did not  induce  autoantibodies  to GH. We 
conclude that reovirus type 1 infection can lead to polyendocrinopathy and autoim- 
munity and that the $1  gene segment is required for the induction of autoantibodies 
to GH. 
We thank Tecolia Brown,  Clifton Link and Royd Ellis for technical help, and Edith Rian for 
editorial assistance. 
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